Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients

RJ Stratta, MS Shaefer, KA Cushing, RS Markin… - …, 1991 - journals.lww.com
During a 38-month period, we studied 320 liver transplants in 283 recipients (202 adults, 81
children). CMV disease was documented in 85 patients (30.0%). The major risk factor for …
被引用次数：55 相关文章

[引用][C] Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients

RJ STRATTA, MS SHAEFER, S LI… - …, 1991 - pascal-francis.inist.fr
Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver
transplant recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients

RJ Stratta, MS Shaefer, KA Cushing… - …, 1991 - pubmed.ncbi.nlm.nih.gov
During a 38-month period, we studied 320 liver transplants in 283 recipients (202 adults, 81
children). CMV disease was documented in 85 patients (30.0%) The major risk factor for …

Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients.

RJ Stratta, MS Shaefer, KA Cushing, RS Markin… - …, 1991 - europepmc.org
Conclusion Primary CMV exposure is a major risk factor for CMV disease in liver transplant
recipients. Intravenous IgG plus acyclovir is safe and effective in preventing CMV infection …

Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients

RJ Stratta, MS Shaefer, KA Cushing… - …, 1991 - experts.nebraska.edu
During a 38-month period, we studied 320 liver trans-plants in 283 recipients (202 adults, 81
children). CMV disease was documented in 85 patients (30.0%). The major risk factor for …

[引用][C] SUCCESSFUL PROPHYLAXIS OF CYTOMEGALOVIRUS DISEASE AFTER PRIMARY CMV EXPOSURE IN LIVER TRANSPLANT RECIPIENTS

RJ STRATTA, MS SHAEFER… - …, 1991 - Lippincott Williams & Wilkins